Zobrazeno 1 - 10
of 220
pro vyhledávání: '"U. Dunzendorfer"'
Publikováno v:
Andrologia. 15:135-140
Summary In an open investigation 20 patients with a history of chronic abacterial prostatitis (24 month duration) and of multiple therapies were treated by 0.07 –0.15/kg Na-tartrate. Na-tartrate, a known inhibitor of the prostatic fraction of acid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1882b4dee4c145adef40ec9f57a24ba
https://doi.org/10.1111/j.1439-0272.1983.tb00126.x
https://doi.org/10.1111/j.1439-0272.1983.tb00126.x
Publikováno v:
The Prostate. 17:85-93
This randomized, placebo-controlled, double-blind study was performed to evaluate the efficacy and safety of once-a-day terazosin (10 mg/day) in ambulatory patients (n = 57) with benign prostatic hyperplasia (BPH). After a 4-week placebo lead-in and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df6d8d9be40d0998fd9723b9baeedd1
https://doi.org/10.1002/pros.2990170509
https://doi.org/10.1002/pros.2990170509
Autor:
F. Keuppens, L. Janzon, Norbert Brock, N. Brock, Herbert Oelschläger, J. Heising, D. Bergqvist, Martin R. Schneider, C. Mahler, L. Denis, P. Pompeius, U. Dunzendorfer, I. Vetter, Dennis L. Citrin, Udo Dunzendorfer, P. Schulz, P. Kristiansen, Helmut Schönenberger, H. Oelschläger, Gerald P. Murphy, F. Fittler, P. Van Erps, Dietrich Rothley, H.W. Bauer, P. Nowé, Leszek Jeromin
Publikováno v:
Urologia Internationalis. 43:I-IV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7f387423116eb69c0e0b54ef7a7615d
https://doi.org/10.1159/000281425
https://doi.org/10.1159/000281425
Publikováno v:
Urologia Internationalis. 38:162-165
Difluoromethylornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG), inhibitors of orni-thine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (AMDC), respectively, were tested for antitu-mor activity in the BALB/C mouse renal ade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3743b9dc014cbadb9aa807c1873aae3
https://doi.org/10.1159/000280882
https://doi.org/10.1159/000280882
Publikováno v:
Oncology. 38:286-291
C-reactive protein (CRP) has been found to be ubiquitous in sera when determined by a highly sensitive method such as radioimmunoassay. Patients with some tumors appear to have much higher serum level
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f161c71d213c476d98387a0cc5229ad1
https://doi.org/10.1159/000225572
https://doi.org/10.1159/000225572
Publikováno v:
Urologia Internationalis. 34:190-198
Serum level of peptide hormones LH, FSH, TSH and prolactin have been measured in patients with urogenital tumor. In this randomized study we found a frequent elevation of TSH and prolactin, which did not correlate. Increased serum level of TSH was co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c40bfb19a6b7006dabfafd43be459443
https://doi.org/10.1159/000280266
https://doi.org/10.1159/000280266
Autor:
D. Drahovsky, U. Dunzendorfer
Publikováno v:
Urologia Internationalis. 35:369-374
Patients with benign hyperplasia of the prostate (BHP) were studied in relation to aberrant serum c-peptide, testosterone, estrone, cortisol and morning fasting glucose, to analyze the syntropy of diabetes and BHP. The results were compared to patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b830d425b48b88363f4308afaebe8da
https://doi.org/10.1159/000280350
https://doi.org/10.1159/000280350
Publikováno v:
Aktuelle Urologie. 16:239-243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::566739e9384da9f43a06226db7315315
https://doi.org/10.1055/s-2008-1062584
https://doi.org/10.1055/s-2008-1062584
Autor:
U. Dunzendorfer
Publikováno v:
Clinica Chimica Acta. 64:87-90
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebd83425dcf9e42c65252c15888423ba
https://doi.org/10.1016/0009-8981(75)90149-7
https://doi.org/10.1016/0009-8981(75)90149-7
Autor:
U. Dunzendorfer
Publikováno v:
Urologia Internationalis. 36:128-136
Multiple oral doses of alpha-difluoromethyl-ornithine (alpha-DFMO), 18-24 g/day for up to 2 months, were administered to 2 patients with invasive and metastatic carcinoma of the bladder and to 3 patients with metastatic renal cancer in an open study.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672cb7fb5316eec25963f0d920769b19
https://doi.org/10.1159/000280403
https://doi.org/10.1159/000280403